Siegall added that for T-cell lymphoma, the current four-drug cocktail offers patients a 45% remission rate, but by replacing just one of those drugs with one of Seattle Genetics', the remission rate has jumped to 88%. Additionally, Siegall noted that by removing one of the more toxic drugs from the mix, patients are gaining additional benefits from fewer side effects.
Siegall also spoke about the importance of his company's many partnerships. He said Seattle Genetics currently has 12 such agreements, where the company shares technology with other companies in return for revenue, milestones and royalties down the road.
Cramer called Seattle Genetics one of the year's biggest winners and shares are not done heading higher.
Executive Decision: Manny Chirico
In his second "Executive Decision" segment, Cramer sat down with Manny Chirico, chairman and CEO of PVH Corp (PVH), the apparel maker that offered tepid guidance for the rest of 2013, yet has seen its shares rise 19% since Cramer last checked in with the company on June 12.Chirico explained that despite a strong performance in the quarter, he's seeing volatility from the global consumer and is no longer as bullish as he once was. He said PVH continues to try and understand the consumer better, but so far this quarter the company expected sales to be more robust. Chirico clarified by indicating that PVH still expects to see a strong fourth quarter for the holiday season, but the back-to-school season thus far included a weak July, a strong August and a soft September thus far, so it remains a challenging environment. Another challenge for the company: Europe, specifically southern Europe, including Italy and Spain, two big markets for PVH. Chirico said that while things in the northern countries have been improving, Italy and Spain remain difficult and are not recovering as quickly. Other challenges for PVH included the Calvin Klein jeans business, where Chirico said the company will be making big investments to regain lost market share. The turnaround in this segment of the business may take 12 to 24 months to complete, Chirico indicated, but he remains confident the distribution and other elements can be cleaned up for big gains later on.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts